Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCR Followed by Lenalidomide Consolidation in Previously Untreated CLL or SLL
NCT00602836Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2008
- Primary completion
- Dec 2010
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, pentostatin, cyclophosphamide, rituximab in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), sponsored by Mayo Clinic. Started Feb 2008; status: completed.
02
Drugs
lenalidomidepentostatincyclophosphamiderituximab
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00602836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00602836.